The history of Merck & Co. dates back to 1668, when Friedrich Jacob Merck bought a pharmacy in Darmstadt. This later evolved into one of the largest pharmaceutical corporations in the world. Learn the latest information and analysis on the company, MRK stock price today, stock news, how much one share costs and other information to help you make investment decisions.
Check out Gainy to see insights on stock prices and more.
Merck & Co. was founded in 1891 as a subsidiary of Merck and now operates separately from its German counterpart. Merck makes treatments for oncology, acute care, immunology, neuroscience, virology, cardiovascular, diabetes, vaccines, and other products. Merck is the market leader in oncology, growing twice as fast as its competition.
The company has a forward PE of 15x compared to the industry’s 23x, and is expected to repeat or beat its 2021 revenue growth of 17% this year.
The Merck stock price is close to its November 2021 all-time highs of $91.40, trading at $88 (as of May 9, 2022). And yet the stock appears to be trading 15% below its fair value, with potential for 150% returns in the next five years. Many analysts are very optimistic about this one.
Check back to this page for the MRK stock quote or download Gainy to see if MRK fits your portfolio and investment goals, get other stock quotes and personal recommendations.
